XTL Biopharmaceuticals Ltd. (XTLB)
NASDAQ: XTLB · Real-Time Price · USD
0.8500
-0.0233 (-2.67%)
At close: Dec 5, 2025, 4:00 PM EST
0.8501
+0.0001 (0.01%)
After-hours: Dec 5, 2025, 5:49 PM EST
XTL Biopharmaceuticals Market Cap
XTL Biopharmaceuticals has a market cap or net worth of $8.16 million as of December 5, 2025. Its market cap has decreased by -62.56% in one year.
Market Cap
8.16M
Enterprise Value
7.03M
1-Year Change
-62.56%
Ranking
Category
Stock Price
$0.85
Market Cap Chart
Since August 31, 2005, XTL Biopharmaceuticals's market cap has decreased from $179.98M to $8.16M, a decrease of -95.47%. That is a compound annual growth rate of -14.15%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |